Intec Pharma Ltd是一家以色列的药物开发公司。该公司是一家处于发展阶段的生物制药公司,使用其专有的胃滞留技术Accordion Pill开发药物配方。Accordion Pill是一种新型的胃滞留递送系统,可改善各种药物的药代动力和药效。该公司专注于Accordion Pill卡比多巴左旋多巴(AP-CDLD)的III期临床研究的临床开发计划,用于治疗晚期帕金森病患者。该公司的产品线还包括用于睡眠发作的药物Accordion Pill-Zaleplon,该药物正处于II期临床计划中。此外,该公司正在研究Accordion Pill-Undisclosed Drug,用于预防和治疗小肠非甾体抗炎药(NSAID)引起的溃疡。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| David Elliot Lazar | Chairman & Co-CEO | 2025 | 35 |
| Jeffrey A. Meckler | Co-CEO & Director | 2025 | 59 |
| Michael J. Newman | Founder, Chief Scientific Officer & Director | 2021 | 70 |
| Roger James Pomerantz | Independent Director | 2021 | 69 |
| William Bradley Hayes | Independent Director | 2021 | 60 |
| Anthony J. Maddaluna | Independent Director | 2021 | 73 |
| Avraham Shlomo Ben-Tzvi | Director | 2025 | 55 |
| David Natan | Independent Director | 2026 | 73 |
| Matthew C. McMurdo | Director | 2026 | 54 |
| Jerome D. Jabbour | Independent Director | 2026 | 52 |